As of 2025-08-07, the EV/EBITDA ratio of Karuna Therapeutics Inc (KRTX) is -25.17. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. KRTX's latest enterprise value is 12,397.19 mil USD. KRTX's TTM EBITDA according to its financial statements is -492.49 mil USD. Dividing these 2 quantities gives us the above KRTX EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 11.0x - 13.4x | 13.0x |
| Forward P/E multiples | 16.7x - 32.2x | 19.9x |
| Fair Price | (211.23) - (168.11) | (207.49) |
| Upside | -164.0% - -151.0% | -162.9% |
| Date | EV/EBITDA |